A protective role of IL-37 in cancer: A new hope for cancer patients

Journal of Leukocyte Biology

Volumn 101, Issue 2, 2017, Pages 395-406

  Abulkhir, Ayoub ^a,b   Samarani, Suzanne ^a,b   Amre, Devendra ^b   Duval, Michel ^b   Haddad, Elie ^b   Sinnett, Daniel ^b   Leclerc, Jean Marie ^b   Diorio, Caroline ^c   Ahmad, Ali ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c University Laval   (Canada)

Author keywords

IL 18; IL 18BP; IL 18R ; SIGIRR; TIR 8

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 37; INTERLEUKIN 37 RECEPTOR; INTERLEUKIN RECEPTOR; PROTEIN; TIR 8; UNCLASSIFIED DRUG; INTERLEUKIN DERIVATIVE; PROTECTIVE AGENT;

ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER PATIENT; CYTOKINE RELEASE; DRUG MECHANISM; FIBROSARCOMA; GENETIC TRANSCRIPTION; HUMAN; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; MALIGNANT NEOPLASM; MOUTH SQUAMOUS CELL CARCINOMA; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; ALTERNATIVE RNA SPLICING; ANIMAL; BIOLOGICAL MODEL; GENETICS; METABOLISM; NEOPLASM;

ALTERNATIVE SPLICING; ANIMALS; HUMANS; INTERLEUKINS; MODELS, BIOLOGICAL; NEOPLASMS; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION;

EID: 85011397664     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.5RU0816-341R     Document Type: Review

References (87)

1. Ding, V. A., Zhu, Z., Xiao, H., Wakefield, M. R., Bai, Q., Fang, Y. (2016) The role of IL-37 in cancer. Med. Oncol. 33, 68.
2. Van de Veerdonk, F. L., Netea, M. G. (2013) New insights in the immunobiology of IL-1 family members. Front. Immunol. 4, 167.
3. Chen, H. M., Fujita, M. (2015) IL-37: a new player in immune tolerance. Cytokine 72, 113–114.
4. Dinarello, C. A., Bufler, P. (2013) Interleukin-37. Semin. Immunol. 25, 466–468.
5. Dinarello, C. A., Nold-Petry, C., Nold, M., Fujita, M., Li, S., Kim, S., Bufler, P. (2016) Suppression of innate inflammation and immunity by interleukin-37. Eur. J. Immunol. 46, 1067–1081.
6. Kumar, S., McDonnell, P. C., Lehr, R., Tierney, L., Tzimas, M. N., Griswold, D. E., Capper, E. A., Tal-Singer, R., Wells, G. I., Doyle, M. L., Young, P. R. (2000) Identification and initial characterization of four novel members of the interleukin-1 family. J. Biol. Chem. 275, 10308–10314.
7. Smith, D. E., Renshaw, B. R., Ketchem, R. R., Kubin, M., Garka, K. E., Sims, J. E. (2000) Four new members expand the interleukin-1 superfamily. J. Biol. Chem. 275, 1169–1175.
8. Mulero, J. J., Pace, A. M., Nelken, S. T., Loeb, D. B., Correa, T. R., Drmanac, R., Ford, J. E. (1999) IL1HY1: a novel interleukin-1 receptor antagonist gene. Biochem. Biophys. Res. Commun. 263, 702–706.
9. Sims, J. E., Nicklin, M. J., Bazan, J. F., Barton, J. L., Busfield, S. J., Ford, J. E., Kastelein, R. A., Kumar, S., Lin, H., Mulero, J. J., Pan, J., Pan, Y., Smith, D. E., Young, P. R. (2001) A new nomenclature for IL-1-family genes. Trends Immunol. 22, 536–537.
10. Nold, M. F., Nold-Petry, C. A., Zepp, J. A., Palmer, B. E., Bufler, P., Dinarello, C. A. (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol. 11, 1014–1022.
11. Fonseca-Camarillo, G., Furuzawa-Carballeda, J., Yamamoto-Furusho, J. K. (2015) Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease. Cytokine 75, 389–402.
12. Shuai, X., Wei-min, L., Tong, Y. L., Dong, N., Sheng, Z. Y., Yao, Y. M. (2015) Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells. Sci. Rep. 5, 14478.
13. Bufler, P., Gamboni-Robertson, F., Azam, T., Kim, S. H., Dinarello, C. A. (2004) Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem. J. 381, 503–510.
14. Sharaf, N., Nicklin, M. J., di Giovine, F. S. (2014) Long-range DNA interactions at the IL-1/IL-36/IL-37 gene cluster (2q13) are induced by activation of monocytes. Cytokine 68, 16–22.
15. Taylor, S. L., Renshaw, B. R., Garka, K. E., Smith, D. E., Sims, J. E. (2002) Genomic organization of the interleukin-1 locus. Genomics 79, 726–733.
16. Boraschi, D., Lucchesi, D., Hainzl, S., Leitner, M., Maier, E., Mangelberger, D., Oostingh, G. J., Pfaller, T., Pixner, C., Posselt, G., Italiani, P., Nold, M. F., Nold-Petry, C. A., Bufler, P., Dinarello, C. A. (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur. Cytokine Netw. 22, 127–147.
17. Sakai, N., Van Sweringen, H. L., Belizaire, R. M., Quillin, R. C., Schuster, R., Blanchard, J., Burns, J. M., Tevar, A. D., Edwards, M. J., Lentsch, A. B. (2012) Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. J. Gastroenterol. Hepatol. 27, 1609–1616.
18. Kumar, S., Hanning, C. R., Brigham-Burke, M. R., Rieman, D. J., Lehr, R., Khandekar, S., Kirkpatrick, R. B., Scott, G. F., Lee, J. C., Lynch, F. J., Gao, W., Gambotto, A., Lotze, M. T. (2002) Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18, 61–71.
19. Bulau, A.M., Nold, M.F., Li, S., Nold-Petry, C.A., Fink, M., Mansell, A., Schwerd, T., Hong, J., Rubartelli, A., Dinarello, C.A., Bufler, P. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proc. Natl. Acad. Sci. USA 111, 2650–2655.
20. Pan, G., Risser, P., Mao, W., Baldwin, D. T., Zhong, A. W., Filvaroff, E., Yansura, D., Lewis, L., Eigenbrot, C., Henzel, W. J., Vandlen, R. (2001) IL-1H, an interleukin 1-related protein that binds IL-18 receptor/ IL-1Rrp. Cytokine 13, 1–7.
21. Li, S., Neff, C. P., Barber, K., Hong, J., Luo, Y., Azam, T., Palmer, B. E., Fujita, M., Garlanda, C., Mantovani, A., Kim, S., Dinarello, C. A. (2015) Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8. Proc. Natl. Acad. Sci. USA 112, 2497–2502.
22. Sharma, S., Kulk, N., Nold, M. F., Gräf, R., Kim, S. H., Reinhardt, D., Dinarello, C. A., Bufler, P. (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J. Immunol. 180, 5477–5482.
23. Shi, Y., Massagué, J. (2003) Mechanisms of TGF-b signaling from cell membrane to the nucleus. Cell 113, 685–700.
24. Boraschi, D., Tagliabue, A. (2013) The interleukin-1 receptor family. Semin. Immunol. 25, 394–407.
25. Nold-Petry, C. A., Lo, C. Y., Rudloff, I., Elgass, K. D., Li, S., Gantier, M. P., Lotz-Havla, A. S., Gersting, S. W., Cho, S. X., Lao, J. C., Ellisdon, A. M., Rotter, B., Azam, T., Mangan, N. E., Rossello, F. J., Whisstock, J. C., Bufler, P., Garlanda, C., Mantovani, A., Dinarello, C. A., Nold, M. F. (2015) IL-37 requires the receptors IL-18Ra and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat. Immunol. 16, 354–365.
26. Lunding, L., Webering, S., Vock, C., Schröder, A., Raedler, D., Schaub, B., Fehrenbach, H., Wegmann, M. (2015) IL-37 requires IL-18Ra and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice. Allergy 70, 366–373.
27. Thomassen, E., Renshaw, B. R., Sims, J. E. (1999) Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 11, 389–399.
28. Molgora, M., Barajon, I., Mantovani, A., Garlanda, C. (2016) Regulatory role of IL-1R8 in immunity and disease. Front. Immunol. 7, 149.
29. Bulek, K., Swaidani, S., Qin, J., Lu, Y., Gulen, M. F., Herjan, T., Min, B., Kastelein, R. A., Aronica, M., Kosz-Vnenchak, M., Li, X. (2009) The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response. J. Immunol. 182, 2601–2609.
30. Garlanda, C., Riva, F., Polentarutti, N., Buracchi, C., Sironi, M., De Bortoli, M., Muzio, M., Bergottini, R., Scanziani, E., Vecchi, A., Hirsch, E., Mantovani, A. (2004) Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc. Natl. Acad. Sci. USA 101, 3522–3526.
31. Ueno-Shuto, K., Kato, K., Tasaki, Y., Sato, M., Sato, K., Uchida, Y., Sakai, H., Ono, T., Suico, M. A., Mitsutake, K., Tokutomi, N., Kai, H., Shuto, T. (2014) Lipopolysaccharide decreases single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) expression by suppressing specificity protein 1 (Sp1) via the Toll-like receptor 4 (TLR4)-p38 pathway in monocytes and neutrophils. J. Biol. Chem. 289, 18097–18109.
32. Davies, J. M., MacSharry, J., Shanahan, F. (2010) Differential regulation of Toll-like receptor signalling in spleen and Peyer’s patch dendritic cells. Immunology 131, 438–448.
33. Villena, J., Suzuki, R., Fujie, H., Chiba, E., Takahashi, T., Tomosada, Y., Shimazu, T., Aso, H., Ohwada, S., Suda, Y., Ikegami, S., Itoh, H., Alvarez, S., Saito, T., Kitazawa, H. (2012) Immunobiotic Lactobacillus jensenii modulates the Toll-like receptor 4-induced inflammatory response via negative regulation in porcine antigen-presenting cells. Clin. Vaccine Immunol. 19, 1038–1053.
34. Nanthakumar, N., Meng, D., Goldstein, A. M., Zhu, W., Lu, L., Uauy, R., Llanos, A., Claud, E. C., Walker, W. A. (2011) The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS One 6, e17776.
35. Zhao, J., Bulek, K., Gulen, M. F., Zepp, J. A., Karagkounis, G., Martin, B. N., Zhou, H., Yu, M., Liu, X., Huang, E., Fox, P. L., Kalady, M. F., Markowitz, S. D., Li, X. (2015) Human colon tumors express a dominantnegative form of SIGIRR that promotes inflammation and colitisassociated colon cancer in mice. Gastroenterology 149, 1860–1871.e8.
36. Grimsby, S., Jaensson, H., Dubrovska, A., Lomnytska, M., Hellman, U., Souchelnytskyi, S. (2004) Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity. FEBS Lett. 577, 93–100.
37. Mashima, R., Hishida, Y., Tezuka, T., Yamanashi, Y. (2009) The roles of Dok family adapters in immunoreceptor signaling. Immunol. Rev. 232, 273–285.
38. Bode, J. G., Ehlting, C., Häussinger, D. (2012) The macrophage response towards LPS and its control through the p38 (MAPK)-STAT3 axis. Cell. Signal. 24, 1185–1194.
39. Zeng, M., Dang, W., Chen, B., Qing, Y., Xie, W., Zhao, M., Zhou, J. (2016) IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response. Clin. Rheumatol. 35, 2251–2258.
40. Quirk, S., Agrawal, D. K. (2014) Immunobiology of IL-37: mechanism of action and clinical perspectives. Expert Rev. Clin. Immunol. 10, 1703–1709.
41. Bulau, A. M., Fink, M., Maucksch, C., Kappler, R., Mayr, D., Wagner, K., Bufler, P. (2011) In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis. Sci. World J. 11, 2480–2490.
42. Wu, B., Meng, K., Ji, Q., Cheng, M., Yu, K., Zhao, X., Tony, H., Liu, Y., Zhou, Y., Chang, C., Zhong, Y., Zhu, Z., Zhang, W., Mao, X., Zeng, Q. (2014) Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice. Clin. Exp. Immunol. 176, 438–451.
43. Yang, Y., Zhang, Z. X., Lian, D., Haig, A., Bhattacharjee, R. N., Jevnikar, A. M. (2015) IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury. Kidney Int. 87, 396–408.
44. McNamee, E. N., Masterson, J. C., Jedlicka, P., McManus, M., Grenz, A., Collins, C. B., Nold, M. F., Nold-Petry, C., Bufler, P., Dinarello, C. A., Rivera-Nieves, J. (2011) Interleukin 37 expression protects mice from colitis. Proc. Natl. Acad. Sci. USA 108, 16711–16716.
45. Coll-Miró, M., Francos-Quijorna, I., Santos-Nogueira, E., Torres-Espin, A., Bufler, P., Dinarello, C. A., López-Vales, R. (2016) Beneficial effects of IL-37 after spinal cord injury in mice. Proc. Natl. Acad. Sci. USA 113, 1411–1416.
46. Barry, J., Loh, Z., Collison, A., Mazzone, S., Lalwani, A., Zhang, V., Davidson, S., Wybacz, E., Garlanda, C., Mantovani, A., Mattes, J., Foster, P. S., Phipps, S. (2013) Absence of Toll-IL-1 receptor 8/single immunoglobulin IL-1 receptor-related molecule reduces house dust mite-induced allergic airway inflammation in mice. Am. J. Respir. Cell Mol. Biol. 49, 481–490.
47. Garlanda, C., Anders, H. J., Mantovani, A. (2009) TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization. Trends Immunol. 30, 439–446.
48. Luo, Y., Cai, X., Liu, S., Wang, S., Nold-Petry, C. A., Nold, M. F., Bufler, P., Norris, D., Dinarello, C. A., Fujita, M. (2014) Suppression of antigenspecific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc. Natl. Acad. Sci. USA 111, 15178–15183.
49. Xu, W. D., Zhao, Y., Liu, Y. (2015) Insights into IL-37, the role in autoimmune diseases. Autoimmun. Rev. 14, 1170–1175.
50. Watson, M. B., Costello, D. A., Carney, D. G., McQuillan, K., Lynch, M. A. (2010) SIGIRR modulates the inflammatory response in the brain. Brain Behav. Immun. 24, 985–995.
51. Blok, D. C., van Lieshout, M. H., Hoogendijk, A. J., Florquin, S., de Boer, O. J., Garlanda, C., Mantovani, A., van’t Veer, C., de Vos, A. F., van der Poll, T. (2014) Single immunoglobulin interleukin-1 receptor-related molecule impairs host defense during pneumonia and sepsis caused by Streptococcus pneumoniae. J. Innate Immun. 6, 542–552.
52. Véliz Rodriguez, T., Moalli, F., Polentarutti, N., Paroni, M., Bonavita, E., Anselmo, A., Nebuloni, M., Mantero, S., Jaillon, S., Bragonzi, A., Mantovani, A., Riva, F., Garlanda, C. (2012) Role of Toll interleukin-1 receptor (IL-1R) 8, a negative regulator of IL-1R/Toll-like receptor signaling, in resistance to acute Pseudomonas aeruginosa lung infection. Infect. Immun. 80, 100–109.
53. Moretti, S., Bozza, S., Oikonomou, V., Renga, G., Casagrande, A., Iannitti, R. G., Puccetti, M., Garlanda, C., Kim, S., Li, S., van de Veerdonk, F. L., Dinarello, C. A., Romani, L. (2014) IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis. PLoS Pathog. 10, e1004462.
54. Riva, F., Bonavita, E., Barbati, E., Muzio, M., Mantovani, A., Garlanda, C. (2012) TIR8/SIGIRR is an interleukin-1 receptor/Toll like receptor family member with regulatory functions in inflammation and immunity. Front. Immunol. 3, 322.
55. Sham, H. P., Yu, E. Y., Gulen, M. F., Bhinder, G., Stahl, M., Chan, J. M., Brewster, L., Morampudi, V., Gibson, D. L., Hughes, M. R., McNagny, K. M., Li, X., Vallance, B. A. (2013) SIGIRR, a negative regulator of TLR/IL-1R signalling promotes microbiota dependent resistance to colonization by enteric bacterial pathogens. PLoS Pathog. 9, e1003539.
56. Ballak, D. B., van Diepen, J. A., Moschen, A. R., Jansen, H. J., Hijmans, A., Groenhof, G. J., Leenders, F., Bufler, P., Boekschoten, M. V., Müller, M., Kersten, S., Li, S., Kim, S., Eini, H., Lewis, E. C., Joosten, L. A., Tilg, H., Netea, M. G., Tack, C. J., Dinarello, C. A., Stienstra, R. (2014) IL-37 protects against obesity-induced inflammation and insulin resistance. Nat. Commun. 5, 4711.
57. Gulen, M. F., Kang, Z., Bulek, K., Youzhong, W., Kim, T. W., Chen, Y., Altuntas, C. Z., Sass Bak-Jensen, K., McGeachy, M. J., Do, J. S., Xiao, H., Delgoffe, G. M., Min, B., Powell, J. D., Tuohy, V. K., Cua, D. J., Li, X. (2010) The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32, 54–66.
58. Bufler, P., Azam, T., Gamboni-Robertson, F., Reznikov, L. L., Kumar, S., Dinarello, C. A., Kim, S. H. (2002) A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc. Natl. Acad. Sci. USA 99, 13723–13728.
59. Banda, N. K., Vondracek, A., Kraus, D., Dinarello, C. A., Kim, S. H., Bendele, A., Senaldi, G., Arend, W. P. (2003) Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J. Immunol. 170, 2100–2105.
60. Nold, M., Hauser, I. A., Höfler, S., Goede, A., Eberhardt, W., Ditting, T., Geiger, H., Pfeilschifter, J., Mühl, H. (2003) IL-18BPa: Fc cooperates with immunosuppressive drugs in human whole blood. Biochem. Pharmacol. 66, 505–510.
61. Samarani, S., Allam, O., Sagala, P., Aldabah, Z., Jenabian, M. A., Mehraj, V., Tremblay, C., Routy, J. P., Amre, D., Ahmad, A. (2016) Imbalanced production of IL-18 and its antagonist in human diseases, and its implications for HIV-1 infection. Cytokine 82, 38–51.
62. Garlanda, C., Riva, F., Veliz, T., Polentarutti, N., Pasqualini, F., Radaelli, E., Sironi, M., Nebuloni, M., Zorini, E. O., Scanziani, E., Mantovani, A. (2007) Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res. 67, 6017–6021.
63. Xiao, H., Gulen, M. F., Qin, J., Yao, J., Bulek, K., Kish, D., Altuntas, C. Z., Wald, D., Ma, C., Zhou, H., Tuohy, V. K., Fairchild, R. L., de la Motte, C., Cua, D., Vallance, B. A., Li, X. (2007) The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26, 461–475.
64. Xiao, H., Yin, W., Khan, M. A., Gulen, M. F., Zhou, H., Sham, H. P., Jacobson, K., Vallance, B. A., Li, X. (2010) Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apcmin mice. Gastroenterology 139, 574–585.
65. Bertilaccio, M. T., Simonetti, G., Dagklis, A., Rocchi, M., Rodriguez, T. V., Apollonio, B., Mantovani, A., Ponzoni, M., Ghia, P., Garlanda, C., Caligaris-Cappio, F., Muzio, M. (2011) Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models. Blood 118, 660–669.
66. Henry, C. J., Casás-Selves, M., Kim, J., Zaberezhnyy, V., Aghili, L., Daniel, A. E., Jimenez, L., Azam, T., McNamee, E. N., Clambey, E. T., Klawitter, J., Serkova, N. J., Tan, A. C., Dinarello, C. A., DeGregori, J. (2015) Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors. J. Clin. Invest. 125, 4666–4680.
67. Gao, W., Kumar, S., Lotze, M. T., Hanning, C., Robbins, P. D., Gambotto, A. (2003) Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity. J. Immunol. 170, 107–113.
68. Wang, S., An, W., Yao, Y., Chen, R., Zheng, X., Yang, W., Zhao, Y., Hu, X., Jiang, E., Bie, Y., Chen, Z., Ouyang, P., Zhang, H., Xiong, H. (2015) Interleukin 37 expression inhibits STAT3 to suppress the proliferation and invasion of human cervical cancer cells. J. Cancer 6, 962–969.
69. Fernandes, J. V., DE Medeiros Fernandes, T. A., DE Azevedo, J. C., Cobucci, R. N., DE Carvalho, M. G., Andrade, V. S., DE Araújo, J. M. (2015) Link between chronic inflammation and human papillomavirus-induced carcinogenesis [review]. Oncol. Lett. 9, 1015–1026.
70. Naugler, W. E., Karin, M. (2008) The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol. Med. 14, 109–119.
71. Apte, R. N., Voronov, E. (2002) Interleukin-1—a major pleiotropic cytokine in tumor-host interactions. Semin. Cancer Biol. 12, 277–290.
72. Hanahan, D., Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57–70.
73. Zhao, J. J., Pan, Q. Z., Pan, K., Weng, D. S., Wang, Q. J., Li, J. J., Lv, L., Wang, D. D., Zheng, H. X., Jiang, S. S., Zhang, X. F., Xia, J. C. (2014) Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells. Sci. Rep. 4, 5177.
74. Lopez-Vergès, S., Milush, J. M., Pandey, S., York, V. A., Arakawa-Hoyt, J., Pircher, H., Norris, P. J., Nixon, D. F., Lanier, L. L. (2010) CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116, 3865–3874.
75. Zhang, G., Tang, C., Tan, J., Liu, R., Zhou, M., Wu, Z. (2015) [IL-37 inhibits the proliferation, invasion and migration of SMMC-7721 cells in vitro]. Xibao Yu Fenzi Mianyixue Zazhi 31, 1301–1305.
76. Jiang, Y., Wang, Y., Liang, L., Gao, Y., Chen, J., Sun, Y., Cheng, Y., Xu, Y. (2015) IL-37 mediates the antitumor activity in renal cell carcinoma. Med. Oncol. 32, 250.
77. Medina Villaamil, V., Aparicio Gallego, G., Santamarina Caínzos, I., Valladares-Ayerbes, M., Antón Aparicio, L. M. (2012) Searching for Hif1-a interacting proteins in renal cell carcinoma. Clin. Transl. Oncol. 14, 698–708.
78. Ge, G., Wang, A., Yang, J., Chen, Y., Yang, J., Li, Y., Xue, Y. (2016) Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer. J. Exp. Clin. Cancer Res. 35, 13.
79. Frelin, C., Ladoux, A., D’angelo, G. (2000) Vascular endothelial growth factors and angiogenesis. Ann. Endocrinol. (Paris) 61, 70–74.
80. Yang, T., Lin, Q., Zhao, M., Hu, Y., Yu, Y., Jin, J., Zhou, H., Hu, X., Wei, R., Zhang, X., Yang, X., Liu, G., Lu, P., Xu, G., Yang, J., Corry, D. B., Su, S. B., Liu, S., Liu, X. (2015) IL-37 is a novel proangiogenic factor of developmental and pathological angiogenesis. Arterioscler. Thromb. Vasc. Biol. 35, 2638–2646.
81. Lin, L., Wang, J., Liu, D., Liu, S., Xu, H., Ji, N., Zhou, M., Zeng, X., Zhang, D., Li, J., Chen, Q. (2016) Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma. Sci. Rep. 6, 26757.
82. Wang, W. Q., Zhao, D., Zhou, Y. S., Hu, X. Y., Sun, Z. N., Yu, G., Wu, W. T., Chen, S., Kuang, J. L., Xu, G. G., Han, Z. C., Wang, B. M., Yang, J. X., Feng, X. M. (2015) Transfer of the IL-37b gene elicits anti-tumor responses in mice bearing 4T1 breast cancer. Acta Pharmacol. Sin. 36, 528–534.
83. Li, N., Grivennikov, S. I., Karin, M. (2011) The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 19, 429–431.
84. Murata, M., Yoshida, K., Yamaguchi, T., Matsuzaki, K. (2014) Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma. World J. Gastroenterol. 20, 15018–15027.
85. Ngo, D. C., Ververis, K., Tortorella, S. M., Karagiannis, T. C. (2015) Introduction to the molecular basis of cancer metabolism and the Warburg effect. Mol. Biol. Rep. 42, 819–823.
86. Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., Lisanti, M. P. (2016) Cancer metabolism: a therapeutic perspective. Nat. Rev. Clin. Oncol. 2016, 4.
87. Busfield, S. J., Comrack, C. A., Yu, G., Chickering, T. W., Smutko, J. S., Zhou, H., Leiby, K. R., Holmgren, L. M., Gearing, D. P., Pan, Y. (2000) Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics 66, 213–216.